Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Skin Neoplasms × Tablets × Clear all

Sponsor

Conditions

Neoplasms 4 Leukemia, B-Cell 2 Urinary Bladder Neoplasms 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Hyperparathyroidism, Primary 1 Head and Neck Neoplasms 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

aldesleukin 14 Cyclophosphamide 14 fludarabine phosphate 11 fludarabine 11 Interleukin-2 9 Ipilimumab 6 Temozolomide 4 Nivolumab 4 trametinib 2 sonidegib 2 pembrolizumab 2 dabrafenib 2 binimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Sodium Chloride 2 Sirolimus 2 Radiotherapy 2 Radiation 2 Peptides 2 Gefitinib 2 Fluorouracil 2 Dacarbazine 2 Cyclosporine 2 Capecitabine 2 veliparib 1 varlilumab 1 tilsotolimod 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡